These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30312327)

  • 21. Effect of opioid receptor antagonists on hypothalamic-pituitary-adrenal activity in rhesus monkeys.
    Williams KL; Ko MC; Rice KC; Woods JH
    Psychoneuroendocrinology; 2003 May; 28(4):513-28. PubMed ID: 12689609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for alcoholism in the Oklahoma Family Health Patterns project: impact of early life adversity and family history on affect regulation and personality.
    Sorocco KH; Carnes NC; Cohoon AJ; Vincent AS; Lovallo WR
    Drug Alcohol Depend; 2015 May; 150():38-45. PubMed ID: 25813267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of naltrexone administration on dehydroepiandrosterone sulfate levels in male and female participants.
    Ceballos NA; France CR; al'Absi M
    Biol Psychol; 2007 Mar; 74(3):414-6. PubMed ID: 16963172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new biomarker of hedonic eating? A preliminary investigation of cortisol and nausea responses to acute opioid blockade.
    Daubenmier J; Lustig RH; Hecht FM; Kristeller J; Woolley J; Adam T; Dallman M; Epel E
    Appetite; 2014 Mar; 74():92-100. PubMed ID: 24291355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex differences in acute hormonal and subjective response to naltrexone: The impact of menstrual cycle phase.
    Roche DJ; King AC
    Psychoneuroendocrinology; 2015 Feb; 52():59-71. PubMed ID: 25459893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism.
    King AC; Schluger J; Gunduz M; Borg L; Perret G; Ho A; Kreek MJ
    Neuropsychopharmacology; 2002 Jun; 26(6):778-88. PubMed ID: 12007748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of naltrexone maintenance on the response to yohimbine in healthy volunteers.
    Rosen MI; Kosten TR; Kreek MJ
    Biol Psychiatry; 1999 Jun; 45(12):1636-45. PubMed ID: 10376126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.
    Maqueda AE; Valle M; Addy PH; Antonijoan RM; Puntes M; Coimbra J; Ballester MR; Garrido M; González M; Claramunt J; Barker S; Lomnicka I; Waguespack M; Johnson MW; Griffiths RR; Riba J
    Int J Neuropsychopharmacol; 2016 Jul; 19(7):. PubMed ID: 26874330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose Escalation of Naltrexone to Reduce Stress Responses Associated With Opioid Antagonist Induction: A Double-blind Randomized Trial.
    Badaras R; Jovaisa T; Lapinskiene I; Ivaskevicius J
    J Addict Med; 2020; 14(3):253-260. PubMed ID: 31609865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of pharmacodynamic effects following oral administration of crushed morphine sulfate and naltrexone hydrochloride extended-release capsules compared with crushed morphine sulfate controlled-release tablets and placebo in nondependent recreational opioid users.
    Setnik B; Sommerville K; Goli V; Han L; Webster L
    Pain Med; 2013 Aug; 14(8):1173-86. PubMed ID: 23745947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lifetime adversity leads to blunted stress axis reactivity: studies from the Oklahoma Family Health Patterns Project.
    Lovallo WR; Farag NH; Sorocco KH; Cohoon AJ; Vincent AS
    Biol Psychiatry; 2012 Feb; 71(4):344-9. PubMed ID: 22112928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blunted opiate modulation of prolactin response in smoking men and women.
    Shaw D; al'Absi M
    Pharmacol Biochem Behav; 2010 Mar; 95(1):1-5. PubMed ID: 19969014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Onset, magnitude and duration of opioid blockade produced by buprenorphine and naltrexone in humans.
    Schuh KJ; Walsh SL; Stitzer ML
    Psychopharmacology (Berl); 1999 Jul; 145(2):162-74. PubMed ID: 10463317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of the hypothalamic-pituitary-adrenal axis with the opioid antagonist nalmefene.
    Geer EB; Landman RE; Wardlaw SL; Conwell IM; Freda PU
    Pituitary; 2005; 8(2):115-22. PubMed ID: 16379031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blunted opioid regulation of the HPA stress response during nicotine withdrawal: therapeutic implications.
    al'Absi M; Nakajima M; DeAngelis B; Grant J; King A; Grabowski J; Hatsukami D; Allen S
    Stress; 2021 Sep; 24(5):529-540. PubMed ID: 32928024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous opioids inhibit ambulatory blood pressure during naturally occurring stress.
    McCubbin JA; Bruehl S; Wilson JF; Sherman JJ; Norton JA; Colclough G
    Psychosom Med; 1998; 60(2):227-31. PubMed ID: 9560874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subjective effects and safety of whole and tampered morphine sulfate and naltrexone hydrochloride (ALO-01) extended-release capsules versus morphine solution and placebo in experienced non-dependent opioid users: a randomized, double-blind, placebo-controlled, crossover study.
    Stauffer J; Setnik B; Sokolowska M; Romach M; Johnson F; Sellers E
    Clin Drug Investig; 2009; 29(12):777-90. PubMed ID: 19888784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioids and social bonding: naltrexone reduces feelings of social connection.
    Inagaki TK; Ray LA; Irwin MR; Way BM; Eisenberger NI
    Soc Cogn Affect Neurosci; 2016 May; 11(5):728-35. PubMed ID: 26796966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypothalamic-pituitary-adrenal axis response to oral naltrexone in alcoholics during early withdrawal.
    Besirli A; Eşel E; Özsoy S; Turan T
    Pharmacopsychiatry; 2014 Jul; 47(4-5):151-5. PubMed ID: 24936803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anticraving treatment?
    Kiefer F; Jahn H; Otte C; Naber D; Wiedemann K
    Biol Psychiatry; 2006 Jul; 60(1):74-6. PubMed ID: 16483549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.